DIAN-TU Amyloid Removal Trial (ART) in Dominantly Inherited Alzheimer's Disease
DIAN-TU Amyloid Removal Trial (ART) in Dominantly Inherited Alzheimer's Disease
Active, not recruiting · NCT06384573 · Registry updated 2026-07-27Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| DIAN-TU Amyloid Removal Trial (ART) in Dominantly Inherited Alzheimer's Disease | Alzheimer disease, brain disorder, central nervous system disorder, cognitive disorder, dementia, nervous system disorder, neurodegenerative disease, psychiatric disorder, tauopathy | Active, not recruiting | Phase 3 | 2026-07-27 | NCT06384573 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Alzheimer's Association | 36 |
| Eisai Inc. | 40 |
| Washington University School of Medicine | 475 |
6 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Indiana University School of Medicine | Indianapolis | United States | 71 |
| Neuroscience Research Australia | Randwick | Australia | 12 |
| The National Hospital for Neurology and Neurosurgery | London | United Kingdom | 5 |
| University of Alabama in Birmingham | Birmingham | United States | 7 |
| University of Washington | Seattle | United States | 172 |
| Washington University in St. Louis | St Louis | United States | 79 |